Miika Arvonen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Miika Arvonen has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Broomfield
Willink Biochemical Genetics Unit, Manchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester Foundation Trust, Manchester, M13 9WL, UK.
2 shared publications - Arunabha Ghosh
St. Mary's Hospital, Manchester University NHS Foundation Trust
2 shared publications - Fiona J. White
Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK
2 shared publications - Javier de Las Heras
Congenital Metabolic Disorders and Metabolic Liver Disease Laboratory, Biobizkaia Health Research Institute, 48093 Barakaldo, Spain; Division of Paediatric Metabolism, CIBERER, MetabERN, Cruces University Hospital, 48093 Barakaldo, Spain; Department of Paediatrics, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain; AECOM Asociación Española para el Estudio de los Errores Congénitos del Metabolismo, Spain
2 shared publications - John Jay Gargus
Departments of Pediatrics, Medical Genetics & Genomics, Physiology & Biophysics and Center for Autism Research & Translation, University of California, Irvine, Irvine, United States, USA
2 shared publications - Matthew Laurence Stoll
University of Alabama at Birmingham
2 shared publications
Latest Publications
- 16 December 2025
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 67 (3) , 592-599
Sepsis and mucositis-related biomarkers in adult hematologic patients with febrile neutropenia
Febrile neutropenia (FN) is a common complication of chemotherapy and potentially fatal. It is often associated with mucositis. Timely recognition of complications enables early supportive treatment and potentially reduces mortality. Common diagnostic parameters are often nonspecific or have slow kinetics. This study examines the applicability of mucosa-related biomarkers in the recognition of complicated course among 78 adult hematologic patients with FN after intensive chemotherapy. Plasma concentrations of citrulline, intestinal fatty acid binding protein (I-FABP), zonula occludens-1 (ZO-1) and alpha-1 acid glycoprotein (α1AGP), as well as C-reactive protein (CRP) and procalcitonin (PCT), were measured at the onset of fever and the following two days. All except ZO-1 showed a significant trend. Concentrations of CRP, PCT, citrulline and α1AGP were higher with a complicated course. Patients with severe sepsis had higher levels of PCT and lower levels of I-FABP. In conclusion, measurement of mucosa-related biomarkers might help predict the course of FN.
- 16 December 2025
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 67 (3) , 592-599
Sepsis and mucositis-related biomarkers in adult hematologic patients with febrile neutropenia
Febrile neutropenia (FN) is a common complication of chemotherapy and potentially fatal. It is often associated with mucositis. Timely recognition of complications enables early supportive treatment and potentially reduces mortality. Common diagnostic parameters are often nonspecific or have slow kinetics. This study examines the applicability of mucosa-related biomarkers in the recognition of complicated course among 78 adult hematologic patients with FN after intensive chemotherapy. Plasma concentrations of citrulline, intestinal fatty acid binding protein (I-FABP), zonula occludens-1 (ZO-1) and alpha-1 acid glycoprotein (α1AGP), as well as C-reactive protein (CRP) and procalcitonin (PCT), were measured at the onset of fever and the following two days. All except ZO-1 showed a significant trend. Concentrations of CRP, PCT, citrulline and α1AGP were higher with a complicated course. Patients with severe sepsis had higher levels of PCT and lower levels of I-FABP. In conclusion, measurement of mucosa-related biomarkers might help predict the course of FN.
- Open Access
- 16 September 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (9) , e9166
Diagnostic challenge of an untypical cutaneous drug reaction from modafinil
Key Clinical Message: Modafinil used for narcolepsy caused an atypical adverse reaction, as itchy acneiform lesions, subcutaneous nodules and superficial skin wounds after 2 years of use. After extensive examinations for 5 years, modafinil was discontinued, and the healing process began in 3 weeks with completion in 1.5 years.
- 16 September 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (9) , e9166
Open AccessDiagnostic challenge of an untypical cutaneous drug reaction from modafinil
Key Clinical Message: Modafinil used for narcolepsy caused an atypical adverse reaction, as itchy acneiform lesions, subcutaneous nodules and superficial skin wounds after 2 years of use. After extensive examinations for 5 years, modafinil was discontinued, and the healing process began in 3 weeks with completion in 1.5 years.
- Open Access
- 15 March 2024
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 44 (3) , 1-13
Germline HAVCR2/TIM-3 Checkpoint Inhibitor Receptor Deficiency in Recurrent Autoinflammatory Myocarditis
Myocarditis can be caused by viral infection, drug reaction or general inflammatory condition. To provide understanding on inflammatory myocarditis, we describe clinical, genetic, and immunological properties of a young male patient who suffered from recurrent myocarditis episodes since the age of four years. Electrocardiography, troponin I/T, echocardiography, myocardial magnetic resonance imaging and histological findings were consistent with recurrent myocarditis episodes. Homozygous c.245 A > G p.Tyr82Cys pathogenic variant in Hepatitis A Virus Cellular Receptor 2 (HAVCR2) gene encoding T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) receptor was found. Peripheral blood mononuclear cells were collected when the patient was asymptomatic; CD4+ and CD8+ T lymphoblasts, CD56+ natural killer cells and CD14+ monocytes were negative for surface TIM-3 expression. In vitro, TLR4 mediated interleukin-1β (IL-1β) response was high after LPS/ATP stimulation. Clinical symptoms responded to IL-1 receptor antagonist anakinra. TIM-3 p.Tyr82Cys CD4+ and CD8+ T cell proliferation in vitro was unrestrained. Findings on IL-2, interferon gamma, regulatory T cells, signal transducer and activator of transcription (STAT) 1, 3 and 4 phosphorylation, and PD-1 and LAG-3 checkpoint inhibitor receptor analyses were comparable to controls. We conclude that TIM-3 deficiency due to homozygous HAVCR2 c.245 A > G p.Tyr82Cys pathogenic variant in the patient described here is associated with autoinflammatory symptoms limited to early onset recurrent febrile myocarditis. Excessive IL-1β production and defective regulation of T cell proliferation may contribute to this clinical condition responsive to anakinra treatment.
- 15 March 2024
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 44 (3) , 1-13
Open AccessGermline HAVCR2/TIM-3 Checkpoint Inhibitor Receptor Deficiency in Recurrent Autoinflammatory Myocarditis
Myocarditis can be caused by viral infection, drug reaction or general inflammatory condition. To provide understanding on inflammatory myocarditis, we describe clinical, genetic, and immunological properties of a young male patient who suffered from recurrent myocarditis episodes since the age of four years. Electrocardiography, troponin I/T, echocardiography, myocardial magnetic resonance imaging and histological findings were consistent with recurrent myocarditis episodes. Homozygous c.245 A > G p.Tyr82Cys pathogenic variant in Hepatitis A Virus Cellular Receptor 2 (HAVCR2) gene encoding T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) receptor was found. Peripheral blood mononuclear cells were collected when the patient was asymptomatic; CD4+ and CD8+ T lymphoblasts, CD56+ natural killer cells and CD14+ monocytes were negative for surface TIM-3 expression. In vitro, TLR4 mediated interleukin-1β (IL-1β) response was high after LPS/ATP stimulation. Clinical symptoms responded to IL-1 receptor antagonist anakinra. TIM-3 p.Tyr82Cys CD4+ and CD8+ T cell proliferation in vitro was unrestrained. Findings on IL-2, interferon gamma, regulatory T cells, signal transducer and activator of transcription (STAT) 1, 3 and 4 phosphorylation, and PD-1 and LAG-3 checkpoint inhibitor receptor analyses were comparable to controls. We conclude that TIM-3 deficiency due to homozygous HAVCR2 c.245 A > G p.Tyr82Cys pathogenic variant in the patient described here is associated with autoinflammatory symptoms limited to early onset recurrent febrile myocarditis. Excessive IL-1β production and defective regulation of T cell proliferation may contribute to this clinical condition responsive to anakinra treatment.
- Open Access
- 28 November 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Instrumentation and Measurement
- Vol. 73 (00189456) , 1-14
Joint Use of a Low Thermal Resolution Thermal Camera and an RGB Camera for Respiration Measurement
Recently, joint use of thermal camera and RGB camera has emerged as a potential solution for respiration measurement. Bulky and large thermal cameras with high thermal resolution have been mostly used in thermal-imaging-based respiration measurement studies. We aim to present a method for respiration measurement using an RGB camera and a low thermal resolution thermal camera. Thermal cameras with low thermal resolution are small in size and easily portable, allowing flexible and a simple implementation of the measurement system. First, the cameras were calibrated and synchronized using calibration objects and sound analysis tools, respectively. Second, a cross-spectrum mapping method was developed which was followed by the extraction of the respiration signal. Third, the extracted and reference respiration signals were aligned. In the last step of the proposed method, a signal processing framework was applied to the estimated and reference respiration signals. The performance of the cross-spectrum mapping method was visually evaluated. The mapping method performed well when a participant had little to no head movements; however, the performance decreased when head movements were present. Our analysis showed that there is a relatively good agreement between the proposed and the reference respiration measurement methods. The number of breathing cycles from the estimated respiration signal was computed with a decent accuracy. However, the accuracy of measuring breathing rate is low compared to the previous studies. The estimated breathing patterns were measured with better accuracy than in the previous work. This study demonstrates that respiration measurement can be done by the joint use of an RGB camera and thermal camera that has a low thermal resolution, with a decent level of accuracy.
- 28 November 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Instrumentation and Measurement
- Vol. 73 (00189456) , 1-14
Open AccessJoint Use of a Low Thermal Resolution Thermal Camera and an RGB Camera for Respiration Measurement
Recently, joint use of thermal camera and RGB camera has emerged as a potential solution for respiration measurement. Bulky and large thermal cameras with high thermal resolution have been mostly used in thermal-imaging-based respiration measurement studies. We aim to present a method for respiration measurement using an RGB camera and a low thermal resolution thermal camera. Thermal cameras with low thermal resolution are small in size and easily portable, allowing flexible and a simple implementation of the measurement system. First, the cameras were calibrated and synchronized using calibration objects and sound analysis tools, respectively. Second, a cross-spectrum mapping method was developed which was followed by the extraction of the respiration signal. Third, the extracted and reference respiration signals were aligned. In the last step of the proposed method, a signal processing framework was applied to the estimated and reference respiration signals. The performance of the cross-spectrum mapping method was visually evaluated. The mapping method performed well when a participant had little to no head movements; however, the performance decreased when head movements were present. Our analysis showed that there is a relatively good agreement between the proposed and the reference respiration measurement methods. The number of breathing cycles from the estimated respiration signal was computed with a decent accuracy. However, the accuracy of measuring breathing rate is low compared to the previous studies. The estimated breathing patterns were measured with better accuracy than in the previous work. This study demonstrates that respiration measurement can be done by the joint use of an RGB camera and thermal camera that has a low thermal resolution, with a decent level of accuracy.
- 13 December 2019
- Published by Wiley in Immunological Reviews
- Vol. 294 (1) , 9-26
Microbial orchestra in juvenile idiopathic arthritis: Sounds of disarray?
The role of the microbiota in multiple autoimmune diseases, including juvenile idiopathic arthritis (JIA) has earned substantial attention in the last 10 years. Increasing evidence suggests that the microbiota's link to JIA begins in early childhood, as early life events that influence the nature of the microbiota also appear to influence disease risk. In this review, we discuss these early life events including mode of delivery, infant feeding practice, antibiotics exposure, and other events and their impacts on the microbiota and on disease risk; reported abnormalities of the microbiota in children with JIA; mechanisms by which an altered microbiota at birth and later on in childhood may influence disease risk; and the prospects for therapeutic alteration of the microbiota in children with JIA.
- 13 December 2019
- Published by Wiley in Immunological Reviews
- Vol. 294 (1) , 9-26
Microbial orchestra in juvenile idiopathic arthritis: Sounds of disarray?
The role of the microbiota in multiple autoimmune diseases, including juvenile idiopathic arthritis (JIA) has earned substantial attention in the last 10 years. Increasing evidence suggests that the microbiota's link to JIA begins in early childhood, as early life events that influence the nature of the microbiota also appear to influence disease risk. In this review, we discuss these early life events including mode of delivery, infant feeding practice, antibiotics exposure, and other events and their impacts on the microbiota and on disease risk; reported abnormalities of the microbiota in children with JIA; mechanisms by which an altered microbiota at birth and later on in childhood may influence disease risk; and the prospects for therapeutic alteration of the microbiota in children with JIA.
- 1 February 2018
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 123 (2) , S51
Experience of the nutritional management of infantile onset lysosomal acid lipase deficiency (LALD)
- 1 February 2018
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 123 (2) , S51
Experience of the nutritional management of infantile onset lysosomal acid lipase deficiency (LALD)
- 1 February 2018
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 123 (2) , S72-S73
Management guidelines for infantile onset lysosomal acid lipase deficiency (LALD)
- 1 February 2018
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 123 (2) , S72-S73
Management guidelines for infantile onset lysosomal acid lipase deficiency (LALD)
- Open Access
- 22 July 2016
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 14 (1) , 44
Gut microbiota-host interactions and juvenile idiopathic arthritis
Juvenile idiopathic arthritis is the most common form of chronic arthritis in children. There is mounting evidence that the microbiota may influence the disease. Recent observations in several systemic inflammatory diseases including JIA have indicated that abnormalities in the contents of the microbiota may be factors in disease pathogenesis, while other studies in turn have shown that environmental factors impacting the composition of the microbiota, such as delivery mode and early exposure to antibiotics, affect the risk of chronic inflammatory diseases including JIA. Microbial alterations may predispose to JIA through a variety of mechanisms, including impaired immunologic development, alterations in the balances of pro- versus anti-inflammatory bacteria, and low-grade mucosal inflammation. Additional confirmatory studies of microbiota aberrations and their risk factors are needed, as well as additional mechanistic studies linking these alterations to the disease itself. The microbiota may influence the risk of JIA and other systemic inflammatory conditions through a variety of mechanisms. Additional research is required to improve our understanding of the links between the microbiota and arthritis, and the treatment implications thereof.
- 22 July 2016
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 14 (1) , 44
Open AccessGut microbiota-host interactions and juvenile idiopathic arthritis
Juvenile idiopathic arthritis is the most common form of chronic arthritis in children. There is mounting evidence that the microbiota may influence the disease. Recent observations in several systemic inflammatory diseases including JIA have indicated that abnormalities in the contents of the microbiota may be factors in disease pathogenesis, while other studies in turn have shown that environmental factors impacting the composition of the microbiota, such as delivery mode and early exposure to antibiotics, affect the risk of chronic inflammatory diseases including JIA. Microbial alterations may predispose to JIA through a variety of mechanisms, including impaired immunologic development, alterations in the balances of pro- versus anti-inflammatory bacteria, and low-grade mucosal inflammation. Additional confirmatory studies of microbiota aberrations and their risk factors are needed, as well as additional mechanistic studies linking these alterations to the disease itself. The microbiota may influence the risk of JIA and other systemic inflammatory conditions through a variety of mechanisms. Additional research is required to improve our understanding of the links between the microbiota and arthritis, and the treatment implications thereof.
- 15 October 2014
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 42 (3) , 521-526
Repeated Exposure to Antibiotics in Infancy: A Predisposing Factor for Juvenile Idiopathic Arthritis or a Sign of This Group’s Greater Susceptibility to Infections?
Objective.: Previous exposure to antibiotics has been associated with the pathogenesis of several autoimmune diseases. Our objective was to explore whether childhood exposure to antibiotics would be associated with the risk of developing juvenile idiopathic arthritis (JIA).Methods.: The material was collected from national registers containing all children born in 2000–2010 in Finland and diagnosed with JIA by the end of December 2012 (n = 1298) and appropriate controls (n = 5179) matched for age, sex, and place of birth. All purchases of antibiotics were collected from birth until the index date (i.e., the date of special reimbursement for JIA medications). A conditional logistic regression was performed to evaluate the association between the exposure to antibiotics and the risk of JIA.Results.: The risk of JIA increased with the number of antibiotic purchases from birth to the index date: for ≥ 1 purchases versus none, OR 1.6, 95% CI 1.3–1.9 with an upward trend in OR (p < 0.001). Antibiotic groups lincosamides and cephalosporins showed the strongest association with JIA (OR 6.6, 95% CI 3.7–11.7, and OR 1.6, 95% CI 1.4–1.8, respectively). Overall exposure to antibiotics before 2 years of age was associated with an increased risk of JIA (OR 1.4, 95% CI 1.2–1.6), with the trend test of OR (p < 0.001).Conclusion.: Previous early and repeated exposure to antibiotics may predispose individuals to develop JIA. Alternatively, the apparent association may reflect shared susceptibility to infections and JIA.
- 15 October 2014
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 42 (3) , 521-526
Repeated Exposure to Antibiotics in Infancy: A Predisposing Factor for Juvenile Idiopathic Arthritis or a Sign of This Group’s Greater Susceptibility to Infections?
Objective.: Previous exposure to antibiotics has been associated with the pathogenesis of several autoimmune diseases. Our objective was to explore whether childhood exposure to antibiotics would be associated with the risk of developing juvenile idiopathic arthritis (JIA).Methods.: The material was collected from national registers containing all children born in 2000–2010 in Finland and diagnosed with JIA by the end of December 2012 (n = 1298) and appropriate controls (n = 5179) matched for age, sex, and place of birth. All purchases of antibiotics were collected from birth until the index date (i.e., the date of special reimbursement for JIA medications). A conditional logistic regression was performed to evaluate the association between the exposure to antibiotics and the risk of JIA.Results.: The risk of JIA increased with the number of antibiotic purchases from birth to the index date: for ≥ 1 purchases versus none, OR 1.6, 95% CI 1.3–1.9 with an upward trend in OR (p < 0.001). Antibiotic groups lincosamides and cephalosporins showed the strongest association with JIA (OR 6.6, 95% CI 3.7–11.7, and OR 1.6, 95% CI 1.4–1.8, respectively). Overall exposure to antibiotics before 2 years of age was associated with an increased risk of JIA (OR 1.4, 95% CI 1.2–1.6), with the trend test of OR (p < 0.001).Conclusion.: Previous early and repeated exposure to antibiotics may predispose individuals to develop JIA. Alternatively, the apparent association may reflect shared susceptibility to infections and JIA.